Clinical significance of serum total oxidant/antioxidant status in patients with operable and advanced gastric cancer Xue-Fang Du,1 Li-Li Zhang,1 De-Zhong Zhang,2 Lu Yang,1 Ying-Ying Fan,1 Shu-Ping
Fabrication of ultrasmall WS2 quantum dots-coated periodic mesoporous organosilica nanoparticles for intracellular drug delivery and synergistic chemo-photothermal therapy Wenyun Liao,1 Li Zhang,1
Identification of differentially expressed genes and signaling pathways in ovarian cancer by integrated bioinformatics analysis Xiao Yang,1 Shaoming Zhu,2 Li Li,3 Li Zhang,1 Shu Xian,1 Yanqing Wang,1
,1,2,* Fan Xia,1,2,* Jurui Luo,1,2,* Jinli Ma,1,2 Zhaozhi Yang,1,2 Li Zhang,1,2 Yan Feng,1,2 Zhimin Shao,2,3 Xiaoli Yu,1,2 Xiaomao Guo1,2 1Department of Radiation Oncology, Fudan University Shanghai
Expression of G protein-coupled receptor 56 is associated with tumor progression in non-small-cell lung carcinoma patients Yanjie Song,1,* Aiqin Li,1,* Li Zhang,1 Lingling Duan2 1Department of
Yang,1,* Yuhan Chen,3 Xinyu Yang,1,2 Xiyu Dai,1,2 Fenghao Sun,1 Li Zhang,3 Cheng Zhan,1 Mingxiang Feng,1 Qun Wang1 1Department of Thoracic Surgery, Zhongshan Hospital, 2Eight-Year Program Clinical
Impact of gefitinib in early stage treatment on circulating cytokines and lymphocytes for patients with advanced non–small cell lung cancer Jin Sheng,1–3,* Wenfeng Fang,1–3,* Xia Liu,3 Shan Xing,1,2,4 Jianhua Zhan,1,2 Yuxiang Ma,1,2 Yan Huang,1–3 Ningning Zhou,1–3 Hongyun Zhao,1–3 Li Zhang1–3 1State Key Laboratory of Oncology in South China, 2Collaborative Innovation Center for...
The efficacy and safety of nivolumab in previously treated advanced non-small-cell lung cancer: a meta-analysis of prospective clinical trials Jiaxing Huang,1,2,* Yaxiong Zhang,1,2,* Jin Sheng,1,2,* Hongyu Zhang,3 Wenfeng Fang,1,2 Jianhua Zhan,1,2 Ting Zhou,1,2 Ying Chen,1,2 Lin Liu,1,2 Li Zhang1,2 1Department of Medical Oncology, Sun Yat-Sen University Cancer Center, 2State Key...
Cemented allograft-prosthesis composite reconstruction for the proximal femur tumor Li Min, Fan Tang, Hong Duan, Yong Zhou, Wen-li Zhang, Rui Shi, Chong-qi Tu Department of Orthopedics, West China
Randomized double-blind trial of prophylactic topical Evozac® Calming Skin Spray for gefitinib-associated acne-like eruption Yalan Wang,* Yunpeng Yang,* Jinxia Xu, Juan Yu, Xia Liu, Ruizhen Gao, Li
Prognostic significance of PD-L1 expression in patients with gastric cancer in East Asia: a meta-analysis Yong-Xuan Liu, Xin-Shuai Wang, Yu-Feng Wang, Xiao-Chen Hu, Jun-Qiang Yan, Ya-Li Zhang, Wei
Zhou,1,2 Xianguo Chen,1 Song Fan,1 Sheng Tai,1 Changqin Jiang,1 Yifei Zhang,1 Zongyao Hao,1 Jun Zhou,1 Haoqiang Shi,1 Li Zhang,1 Chaozhao Liang1 1Department of Urology, First Affiliated Hospital of Anhui
Human papillomavirus 16 infection predicts poor outcome in patients with esophageal squamous cell carcinoma Ruxing Xi,1 Xiaozhi Zhang,1 Xin Chen,1 Shupei Pan,1 Beina Hui,1 Li Zhang,1 Shenbo Fu,1
University , Zhongshan People's city hospital, Zhongshan , People's Republic of China 1 li Zhang Department of Medical Oncology, sun Yat-sen University cancer center , 651 Dong Feng road east, guangzhou 510060
Li, Ying Guo, Yuanyuan Zhao, Cong Xue, Zhihuang Hu, Li Zhang, Hongyun ZhaoState Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China*These authors
prognostic factors for LCNEC patients. O r i g i n a l; r e s e a r c h - correspondence: li Zhang Department of Medical Oncology, sun Yat-sen University cancer center, state Key laboratory of Oncology in
Risk of treatment-related deaths with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a meta-analysis of 41 randomized controlled trials Shaodong Hong,1,* Wenfeng Fang,1,* Wenhua Liang,1,* Yue Yan,1 Ting Zhou,1 Tao Qin,1 Xuan Wu,1 Yuxiang Ma,1 Yuanyuan Zhao,1 Yunpeng Yang,1 Zhihuang Hu,1 Cong Xue,1 Xue Hou,1 Yue Chen,2 Yan Huang,1 Hongyun Zhao,1 Li Zhang1...
Comparison of different methods for detecting epidermal growth factor receptor mutations in peripheral blood and tumor tissue of non-small cell lung cancer as a predictor of response to gefitinib Fei Xu,1,* Jingxun Wu,2,* Cong Xue,1,* Yuanyuan Zhao,1 Wei Jiang,3 Liping Lin,4 Xuan Wu,5 Yachao Lu,6 Hua Bai,7 Jiasen Xu,8 Guanshan Zhu,6 Li Zhang11State Key Laboratory of Oncology in...